| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S C Cheetham, C J Kettle, K F Martin, D J Hea. D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function. Journal of neural transmission. General section. vol 102. issue 1. 1996-09-20. PMID:8785022. |
the d2-selective antagonist, haloperidol, the non-selective d1/d2 receptor antagonist, chlorpromazine, the dopamine reuptake inhibitors, bupropion, gbr 12909 and nomifensine, and the dopamine releasing agent, d-amphetamine, had no effect on d1 receptors. |
1996-09-20 |
2023-08-12 |
rat |
| I Kusumi, T Ishikane, S Matsubara, T Koyam. Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex. Journal of neural transmission. General section. vol 101. issue 1-3. 1996-09-03. PMID:8695053. |
long-term treatment with haloperidol or clozapine does not affect dopamine d4 receptors in rat frontal cortex. |
1996-09-03 |
2023-08-12 |
rat |
| I Kusumi, T Ishikane, S Matsubara, T Koyam. Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex. Journal of neural transmission. General section. vol 101. issue 1-3. 1996-09-03. PMID:8695053. |
we examined the effects of long-term treatment with haloperidol and clozapine on dopamine d4 receptors in rat frontal cortex. |
1996-09-03 |
2023-08-12 |
rat |
| J Zhang, L Wang, D K Pitt. Prenatal haloperidol reduces the number of active midbrain dopamine neurons in rat offspring. Neurotoxicology and teratology. vol 18. issue 1. 1996-09-03. PMID:8700043. |
prenatal haloperidol reduces the number of active midbrain dopamine neurons in rat offspring. |
1996-09-03 |
2023-08-12 |
rat |
| J Zhang, L Wang, D K Pitt. Prenatal haloperidol reduces the number of active midbrain dopamine neurons in rat offspring. Neurotoxicology and teratology. vol 18. issue 1. 1996-09-03. PMID:8700043. |
the dopamine (da) receptor antagonist, haloperidol (hal, 1.25 or 5 mg/kg), or vehicle, dimethyl sulfoxide (dmso), was administered (sc) daily to pregnant sprague-dawley dams from gestational day (gd) 8 to gd 20. |
1996-09-03 |
2023-08-12 |
rat |
| E Hedlund, A Wyss, T Kainu, M Backlund, C Köhler, M Pelto-Huikko, J A Gustafsson, M Warne. Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. Molecular pharmacology. vol 50. issue 2. 1996-09-03. PMID:8700142. |
no induction of 2d4 was observed with the dopamine d2 receptor blockers haloperidol, chlorpromazine, and sulpiride or with the serotonin receptor blocker mianserin. |
1996-09-03 |
2023-08-12 |
rat |
| K McFarland, A Ettenber. Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology. vol 122. issue 4. 1996-07-30. PMID:8657831. |
the effect of dopamine (da) receptor antagonism on reinforcement and motivational processes was investigated by pretreating subjects with 0.0, 0.15 or 0.30 mg/kg of the da receptor antagonist drug, haloperidol. |
1996-07-30 |
2023-08-12 |
human |
| S Kapur, G Remington, C Jones, A Wilson, J DaSilva, S Houle, R Zipursk. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. The American journal of psychiatry. vol 153. issue 7. 1996-07-29. PMID:8659621. |
high levels of dopamine d2 receptor occupancy with low-dose haloperidol treatment: a pet study. |
1996-07-29 |
2023-08-12 |
Not clear |
| S Kapur, G Remington, C Jones, A Wilson, J DaSilva, S Houle, R Zipursk. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. The American journal of psychiatry. vol 153. issue 7. 1996-07-29. PMID:8659621. |
the purpose of this study was to determine the dopamine d2 receptor occupancy induced by low-dose haloperidol treatment in a prospective trial. |
1996-07-29 |
2023-08-12 |
Not clear |
| V H Sethy, B R Ellerbrock, H W. Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol. Life sciences. vol 58. issue 7. 1996-07-01. PMID:8632711. |
clozapine is an atypical antipsychotic drug, and its dopamine and muscarinic antagonist activity has been compared with haloperidol in rodents. |
1996-07-01 |
2023-08-12 |
mouse |
| V H Sethy, B R Ellerbrock, H W. Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol. Life sciences. vol 58. issue 7. 1996-07-01. PMID:8632711. |
thus, clozapine is antimuscarinic at a dose level that lacks dopamine antagonist properties, whereas haloperidol is a dopamine antagonist and lacks antimuscarinic activity. |
1996-07-01 |
2023-08-12 |
mouse |
| K Yamaguchi, H Hama, K Watanab. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats. European journal of endocrinology. vol 134. issue 2. 1996-06-28. PMID:8630527. |
in order to explore the location of these receptors, we injected (0.5 mul) the dopamine antagonist haloperidol (13.3 nmol) or dopamine (26.4 nmol) topically into the anteroventral third ventricular region or the paraventricular nucleus of rats, and their effects on the levels of plasma vasopressin and its controlling factors were examined in the presence or absence of an osmotic stimulus. |
1996-06-28 |
2023-08-12 |
rat |
| C K Meshul, R K Stallbaumer, C Alle. GM1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat. Psychopharmacology. vol 121. issue 4. 1996-06-12. PMID:8619009. |
(1983a) reported that administration of gm1 ganglioside blocks the increase in dopamine d2 receptors following haloperidol treatment. |
1996-06-12 |
2023-08-12 |
rat |
| W T O'Connor, K L Drew, U Ungersted. Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 15. issue 12. 1996-06-06. PMID:8613768. |
we used in vivo microdialysis to investigate the effects of local perfusion with the ache inhibitor neostigmine on the basal and haloperidol evoked increase in dialysate dopamine levels in the dorsolateral and fundus striata of the bilaterally implanted halothane anaesthetized rat. |
1996-06-06 |
2023-08-12 |
rat |
| W T O'Connor, K L Drew, U Ungersted. Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 15. issue 12. 1996-06-06. PMID:8613768. |
in the absence of neostigmine haloperidol (0.05-0.5 mg/kg, s.c.) increased dopamine release in both the dorsolateral and fundus striata. |
1996-06-06 |
2023-08-12 |
rat |
| W T O'Connor, K L Drew, U Ungersted. Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 15. issue 12. 1996-06-06. PMID:8613768. |
both the basal and haloperidol (0.25 mg/kg) induced increase in dopamine release in the control (no neostigmine) and neostigmine (+10 microm) treated dorsolateral striata were abolished following local perfusion with tetrodotoxin (1 microm). |
1996-06-06 |
2023-08-12 |
rat |
| S M Waters, C S Konkoy, T P Davi. Haloperidol and apomorphine differentially affect neuropeptidase activity. The Journal of pharmacology and experimental therapeutics. vol 277. issue 1. 1996-06-06. PMID:8613907. |
in the present study, the effect of acute and subchronic administration of the neuroleptic haloperidol and the nonselective, dopamine agonist apomorphine on neuropeptidase activity was determined in regional, rat brain p2 membranes. |
1996-06-06 |
2023-08-12 |
rat |
| T Inoue, M Domae, K Yamada, T Furukaw. Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland. The Journal of pharmacology and experimental therapeutics. vol 277. issue 1. 1996-06-06. PMID:8613910. |
in in vitro experiments on the isolated anterior pituitary, the spontaneous prl release was decreased by talipexole, a dopamine d2 receptor full agonist, in a dose-dependent manner to 36% of the basal release, and the decrease was antagonized by haloperidol, a d2 receptor antagonist. |
1996-06-06 |
2023-08-12 |
rat |
| A Verma, B Moghadda. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 16. issue 1. 1996-06-03. PMID:8613804. |
administration of the dopamine antagonists raclopride (0.1 and 0.5 mg/kg), sch-23390 (0.1 mg/kg), or haloperidol (0.1 mg/kg) was without a significant effect. |
1996-06-03 |
2023-08-12 |
rat |
| A F Yakimovskii, E V Filatov. Food-procuring behavior of rats under the conditions of chronic activation and blockade of the neostriatal dopaminergic system. Neuroscience and behavioral physiology. vol 25. issue 5. 1996-05-31. PMID:8614484. |
chronic blockade of dopamine receptors by haloperidol induced the reverse effect. |
1996-05-31 |
2023-08-12 |
rat |